Located in Tampa, Florida, Moffitt Cancer Center (www.moffitt.org) is the only Florida-based cancer center with the NCI designation as a Comprehensive Cancer Center for its excellence in research and contributions to clinical trials, prevention and cancer...
Susan Vadaparampil, co-founder of B-GREAT (Breast Cancer Genetics Research and Education for African American Women Team) - a Tampa-based research team based upon a community and academic partner-ship - will share insights about the organization's mission, services, and research achievements as the event's keynote speaker.
About Susan VadaparampilSusan Vadaparampil is an Associate Member in the Health Outcomes and Behavior Program in the Division of Cancer Prevention and Control at Moffitt Cancer Center.She is an Associate Member in the Department of Oncologic Sciences at the University of South Florida College of Medicine.
Over the past several years, Vadaparampil's research has focused on improving access to and outcomes of genetic counseling and testing for hereditary breast and ovarian cancer.
She is currently funded by a five-year grant from the American Cancer Society to better understand the impact and outcomes of BRCA testing in a large sample of African American breast cancer patients.
In addition to her research, Vadaparampil has been actively involved in education and outreach for African American women about hereditary breast cancer.
PDQ® Cancer Genetics Editorial Board - National Cancer Institute
Susan T. Vadaparampil, PhD, MPH, Associate Professor, Moffitt Cancer Center, University of South Florida, Department of Health Outcomes and Behavior, studies genetic testing for hereditary breast and ovarian cancer.She's specifically interested in how to get testing to women at a time and in a way that makes it most useful for prevention and managing cancer risks.
For Affiliates - Moffitt/Ponce School of Medicine - Biographies - Susan Vadaparampil - H. Lee Moffitt Cancer Center & Research Institute - H. Lee Moffitt Cancer Center & Research Institute
Susan Vadaparampil, Ph.D., M.P.H.Assistant ProfessorH. Lee Moffitt Cancer Center & Research Institute
Dr. Susan Vadaparampil received a her bachelor's and master's degrees in Health Science Education from the University of Florida, an M.P.H. from Johns Hopkins University with an emphasis in Epidemiology, and a Ph.D. in Health Behavior from Indiana University in 2000.She then completed a postdoctoral fellowship in Cancer Prevention at the National Cancer Institute.
Dr. Vadaparampil is currently an Assistant Professor in the Department of Interdisciplinary Oncology at the University of South Florida College of Medicine and a Member-In-Residence in the Health Outcomes and Behavior Program at H. Lee Moffitt Cancer Center.She currently holds an adjunct faculty appointment at the University of South Florida College of Public Health and is an Adjunct Scientist in the Clinical Genetics Branch at the National Cancer Institute.Her research interests focus on awareness, knowledge, and use of genetic testing for inherited cancer susceptibility in the general population, minority groups, physicians and at-risk populations.
In order to further develop these interests, she has successfully obtained peer-reviewed extramural funding from several national agencies.
In January 2006, Dr. Vadaparampil was awarded a five-year American Cancer Society Mentored Research Scholar Grant to explore the impact of genetic counseling on recently diagnosed breast cancer patients.
The specific aims of the study are to examine: factors that predict whether a woman receives genetic counseling during or after she begins her definitive breast cancer treatment; patient satisfaction with BRCA1/2 genetic counseling; and the impact of BRCA1/2 genetic counseling in reducing decisional conflict about proceeding with BRCA1/2 genetic testing.
With the information obtained from the present study, Dr. Vadaparampil will develop interventions designed to optimize the timing, content, and process of BRCA1/2 counseling and testing for breast cancer patients.
In addition, Dr. Vadaparampil also obtained an R03 Grant from the National Human Genome Research Institute.
The specific aims of this study are to apply Social Marketing theory to: examine knowledge, attitudes, and behaviors related to cancer genetics among Mexican, Puerto Rican, and Cuban women at increased risk for hereditary breast and ovarian cancer (HBOC); develop a series of culturally relevant messages related to HBOC and genetic counseling and testing specific to Mexican, Puerto Rican, and Cuban American women at increased risk for HBOC; and identify appropriate dissemination channels for these messages.
Study findings will serve as the basis for a larger intervention trial based in a public health department setting to educate Hispanic women at increased risk for HBOC about genetic counseling and testing for HBOC that will apply the final three phases of Social Marketing including: pretesting, implementation, and evaluation of the messages.
Dr. Vadaparampil also serves as a collaborator/co-investigator on several cancer prevention and control studies in the areas of physician knowledge and use of genetic testing for inherited cancer susceptibility, establishing the prevalence of BRCA1/2 mutations in the African American population, psychosocial aspects of familial testicular cancer, health care provider discussion of fertility preservation among pediatric and young adult cancer patients and their families, and the psychosocial impact of HPV on men.